Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2026

Feb 6, 2026

32093_dirs_2026-02-06_730d72e5-a17f-4758-aadf-e08380ea4d8f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2026-01-08

Reporting Person: Sainz Maria (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-01-08 Stock Option (right to buy) $14.72 A 50000 Acquired 2036-01-08 Common Stock (50000) Direct
2026-02-05 Stock Option (right to buy) $13.69 A 3104 Acquired 2036-02-05 Common Stock (3104) Direct

Footnotes

F1: One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date.

F2: The shares subject to the option will vest in equal installments on March 5, 2026 and June 5, 2026, subject to the Reporting Person's continued service through each vesting date.